ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0118

Sex-Based Variations in Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions

Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Katie Lin1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Eileen Davidson3, Clare Hildebrandt4, Steven Katz2, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

Meeting: ACR Convergence 2022

Keywords: Disparities, gout, Health Services Research, Juvenile idiopathic arthritis, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: High quality ambulatory care provision should mitigate avoidable emergency department (ED) visits by persons with inflammatory arthritis (IA) conditions and address the unique realities of those facing inequities in care. Our objective was to characterize ED use by persons with IA conditions based on female or male identity to inform required ambulatory care service enhancements.

Methods: Estimates of ED utilization were obtained from analyzing population-based data from a universal provincial health system in Alberta, Canada (~4.4 million residents). Validated case definitions were applied to physician claims and hospitalization administrative datasets (years 2002-2018) to create prevalent cohorts of persons with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Juvenile Idiopathic Arthritis (JIA) and gout. Records were then linked to the National Ambulatory Care Reporting System dataset in which ED use is documented with details of presentation (timing, acuity, diagnosis, and disposition). Estimates were stratified by binary sex identity for descriptive analysis; annual estimates for years 2008-2018 were generated to identify possible time trends, and data presented here are from fiscal year 2017-2018.

Results: There were 60,373 persons with an IA condition (26,029 female) with 156,570 ED visits (68,910 by females) in the 2017-2018 fiscal year (Table 1). Females with AS and gout were significantly more likely than males to have at least 1 ED visit (difference for AS 7.5%; 95%CI 6.1, 8.9; difference for gout 11.0%; 95%CI 10.3, 11.8). Assigned acuity scores varied by sex with males more frequently assigned ‘1-resuscitation’ and ‘2-emergent’ Canadian Triage & Acuity Scores. For all conditions except JIA, over half of all visits occurred during the day shift (08:00-16:00 hours); females presented at a higher frequency during the evening shift (16:01-22:00 hours) and males during the night shift (22:01-07:59 hours) (p< 0.01). Females with PsA and JIA were significantly more likely than males to present to the ED on a weekday as compared to a weekend or statutory holiday (72.6% vs 68.7%; 71.5% vs 65.0% respectively). The reasons for ED visits were similar between males and females, except for visits for infections being higher in females with JIA (20.1% vs 15.4% of visits), and injuries being higher in males with JIA (31.3% vs 22.6% of visits) (Figure 2). Significantly more males with AS (difference 0.7%; 95%CI 0.2, 1.1) and gout (difference 2.9%; 95%CI 2.7, 3.2) than females with these conditions presented to the ED for a flare, whereas presentations for flares were not different for the other IA conditions. More males with RA returned to the ED within 72 hours of their initial discharge (difference 2.5%; 95%CI 1.2, 3.8). Males with RA, PsA and AS were more frequently admitted to hospital (difference 1.1%, 3.9% and 1.4% respectively, all p< 0.01), whereas females with gout were more frequently admitted (difference 4.0%; 95%CI 3.4, 4.6).

Conclusion: Patterns of ED utilization that vary between females and male persons with different types of IA conditions will need to be recognized in proposed health system solutions aiming to reduce avoidable acute care use.

Supporting image 1

Table 1. Emergency Department Visits by Females and Males with Inflammatory Arthritis Conditions in Alberta, Canada (fiscal year 2017_2018)

Supporting image 2

Figure 1. Diagnoses from Emergency Department Use by Males and Females with Inflammatory Arthritis Conditions in Alberta, Canada (fiscal year 2017_2018, proportions)


Disclosures: C. Barnabe, Janssen, Fresenius Kabi, Celltrion Healthcare, Pfizer; P. McLane, None; N. Luca, None; K. Lin, None; K. Chomistek, None; M. Elliott, None; S. McQuitty, None; E. Davidson, None; C. Hildebrandt, None; S. Katz, None; B. Holroyd, None; C. Barber, None.

To cite this abstract in AMA style:

Barnabe C, McLane P, Luca N, Lin K, Chomistek K, Elliott M, McQuitty S, Davidson E, Hildebrandt C, Katz S, Holroyd B, Barber C. Sex-Based Variations in Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/sex-based-variations-in-emergency-department-utilization-by-persons-with-inflammatory-arthritis-conditions/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-based-variations-in-emergency-department-utilization-by-persons-with-inflammatory-arthritis-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology